The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A 4 hydrolase (LTA 4 H), and shifts macrophage phenotype
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving and tissue homeostatic actions. Maresin 1 (MaR1; 7 R ,14 S ‐dihydroxy‐docosa‐4 Z ,8 E ,10 E ,12 Z ,16 Z ,19 Z ‐hexaenoic acid) is the first identified maresin. Here, we investigate formation, stereochemistry, and precursor role of 13,14‐epoxy‐docosahexaenoic acid, an intermediate in MaR1 biosynthesis. The 14‐lipoxygenation of DHA by human macrophage 12‐lipoxygenase (hm12‐LOX) gave 14‐hydro(peroxy)‐docosahexaenoic acid (14‐HpDHA), as well as several dihydroxy‐docosahexaenoic acids, implicating an epoxide intermediate formation by this enzyme. Using a stereo‐controlled synthesis, enantiomerically pure 13 S ,14 S ‐epoxy‐docosa‐4 Z ,7 Z ,9 E ,11 E ,16 Z ,19 Z ‐hexaenoic acid (13 S ,14 S ‐epoxy‐DHA) was prepared, and its stereochemistry was confirmed by NMR spectroscopy. When this 13 S ,14 S ‐epoxide was incubated with human macrophages, it was converted to MaR1. The synthetic 13 S ,14 S ‐epoxide inhibited leukotriene B 4 (LTB 4 ) formation by human leukotriene A 4 hydrolase (LTA 4 H) ~40% ( P <0.05) to a similar extent as LTA4 (~50%, P <0.05) but was not converted to MaR1 by this enzyme. 1 3S ,14 S ‐epoxy‐DHA also reduced (~60%; P <0.05) arachidonic acid conversion by hm12‐LOX and promoted conversion of M1 macrophages to M2 phenotype, which produced more MaR1 from the epoxide than M1. Together, these findings establish the biosynthesis of the 13 S ,14 S ‐epoxide, its absolute stereochemistry, its precursor role in MaR1 biosynthesis, and its own intrinsic bioactivity. Given its actions and role in MaR1 biosynthesis, this epoxide is now termed 13,14‐epoxy‐maresin (13,14‐eMaR) and exhibits new mechanisms in resolution of inflammation in its ability to inhibit proinflammatory mediator production by LTA4 hydrolase and to block arachidonate conversion by human 12‐LOX rather than merely terminating phagocyte involvement.—Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., Serhan, C. N. The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H) and shifts macrophage phenotype. FASEB J. 27, 2573–2583 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At least some of these lipid metabolites are produced by macrophages (101) and also signal to macrophages to reduce inflammatory and fibrogenic gene expression (102).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · cited 10×
“In the biosynthesis of MaR1, DHA undergoes 14S-lipoxygenation to give 14-HpDHA that is converted to 13S,14S-epoxy-DHA, a proposed intermediate that is then further transformed to MaR1 (8).”
BackgroundMethodInfluentialSelf-citationResolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695 · cited 1×
“The ability to identify resolvins revealed their remarkable protective actions, including their ability to enhance immune vigilance (23) and to stimulate host immune responses, lowering antibiotic requirements during infection (24).”
BackgroundSelf-citationInfection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664
Self-citationMacrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Serhan, C. N., Dalli, J., Karamnov, S., Choi, A., Park, C., Xu, Z., Ji, R., Zhu, M., & Petasis, N. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-201442 · Cited by 595 · cited 7×
“We next determined the identity of these DHA-derived products by assessing their respective MS-MS spectra and matching with synthetic and/or authentic standards (11).”
BackgroundInfluentialSelf-citationShimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576 · cited 1×
“3 min that corresponded to the known nonenzymatic hydrolysis products of LTA4 (3, 4) with the major peak at TR 5.”
Backgroundn–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Self-citationFatty acids and inflammation: The cutting edge between food and pharma
Calder, P. C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.085 · Cited by 516 · cited 1×
“It is now well appreciated that -3 fatty acids exert a positive bearing on several important aspects of cardiovascular disease (30, 31).”
BackgroundMetabolic oxidation regulates embryonic stem cell differentiation
Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sánchez-Ruiz, A., Benton, H. P., Trauger, S. A., Desponts, C., Ding, S., & Siuzdak, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.364 · Cited by 506
Cited by
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Self-citationInflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationProresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
Self-citationThe resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Self-citationSerhan, C. N. (2017) · The FASEB Journal · doi:10.1096/fj.201601222r · Cited by 555
“The MaRs andRvE1were first recognized (43, 44) to stimulate resolution, tissue regeneration, and subsequent wound healing (21, 45).”
BackgroundMethodInfluentialSelf-citationLipid Mediators in the Resolution of Inflammation
Serhan, C. N., Chiang, N., Dalli, J., & Levy, B. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016311 · Cited by 544
“In addition, RvD3 and AT-RvD3 each activates GPR32, contributing to their proresolving actions in stimulating macrophage uptake of microbial particles (Dalli et al. 2013a).”
BackgroundInfluentialSelf-citationSerhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
Self-citationColas, R. A., Shinohara, M., Dalli, J., Chiang, N., & Serhan, C. N. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00024.2014 · Cited by 421
Self-citationLeoni, G., Neumann, P.-A., Kamaly, N., Quiros, M., Nishio, H., Jones, H. R., Sumagin, R., Hilgarth, R. S., Alam, A., Fredman, G., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76693 · Cited by 354
“Furthermore, macrophages generate maresins that exert proresolving effects in inflammation (50, 51).”
Chiang, N., & Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.005 · Cited by 324
“D-series Rv ligands for GPR32 identified recently also include RvD5, RvD3 and AT-RvD3 (Chiang et al., 2012; Dalli et al., 2013a).”
BackgroundMethodInfluentialSelf-citationAchieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis
Bayır, H., Anthonymuthu, T. S., Tyurina, Y. Y., Patel, S. J., Amoscato, A. A., Lamade, A. M., Yang, Q., Vladimirov, G. K., Philpott, C. C., & Kagan, V. E. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.03.014 · Cited by 317
Wound repair: role of immune–epithelial interactions
Leoni, G., Neumann, P.-A., Sumagin, R., Denning, T. L., & Nusrat, A. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.63 · Cited by 302
Resolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
“MaR1 biosynthesis proceeds via a novel 13,14-epoxide intermediate (96).”
BackgroundSelf-citationMarcon, R., Bento, A. F., Dutra, R. C., Bicca, M. A., Leite, D. F. P., & Calixto, J. B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202743 · Cited by 293
“Corroborating our findings, a very recent study showed that 13S,14S-epoxy-DHA, also termed 13S,14S-epoxymaresin, an MaR1 precursor, promoted conversion of M1 macrophages to the M2 phenotype (12).”
ResultDHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 286
“RvD1, its aspirin triggered epimer AT-RvD1, RvD3, and RvD5 have all been shown to bind and signal through the DRV1 receptor (Chiang et al., 2012; Dalli et al., 2013a; Krishnamoorthy et al., 2012; Krishnamoorthy et al., 2010; Sun et al., 2007).”
BackgroundThe role of non-resolving inflammation in atherosclerosis
Kasikara, C., Doran, A. C., Cai, B., & Tabas, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97950 · Cited by 266
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Brennan, E., Kantharidis, P., Cooper, M. E., & Godson, C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00454-y · Cited by 262
Key mechanisms governing resolution of lung inflammation
Robb, C. T., Regan, K. H., Dorward, D. A., & Rossi, A. G. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0560-6 · Cited by 261
Das, U. N. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.01.001 · Cited by 255
New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration
Serhan, C. N., Chiang, N., & Dalli, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.08.002 · Cited by 245
Self-citationResolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Viola, J. R., Lemnitzer, P., Jansen, Y., Csaba, G., Winter, C., Neideck, C., Silvestre-Roig, C., Dittmar, G., Döring, Y., Drechsler, M., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309492 · Cited by 226
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Zhu, M., Wang, X., Hjorth, E., Colas, R. A., Schroeder, L., Granholm, A.-C., Serhan, C. N., & Schultzberg, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9544-0 · Cited by 204
“This finding is in line with an earlier study, in which an increase in the production of MaR1 was associated with decreased levels of the pro-inflammatory markers CD54 and CD80 in interferon (IFN)-γ- and LPS-stimulated macrophages, as well as with increased levels of the antiinflammatory phenotype markers CD163 and CD…”
InfluentialSelf-citationMolecular Mechanisms Modulating the Phenotype of Macrophages and Microglia
Amici, S. A., Dong, J., & Guerau-de-Arellano, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01520 · Cited by 191
“In particular, maresins have been shown to shift to a resolving macrophage phenotype (62), which can also be induced by exposure to Th2 cytokines like IL-4 and IL-13, parasites, fungal cells, apoptotic cells, immune complexes, adenosine, or transforming growth factor (TGF)-β (63).”
BackgroundKrishnamoorthy, N., Burkett, P. R., Dalli, J., Abdulnour, R.-E. E., Colas, R., Ramon, S., Phipps, R. P., Petasis, N. A., Kuchroo, V. K., Serhan, C. N., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402534 · Cited by 188
“Lungs were harvested at the indicated time points, and metabololipidomics were performed as described and matched to authentic MaR1 (7, 14).”
MethodSelf-citationGu, J., Luo, L., Wang, Q., Yan, S., Lin, J., Li, D., Cao, B., Mei, H., Ying, B., Bin, L., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0031-x · Cited by 188
Deng, B., Wang, C.-W., Arnardottir, H. H., Li, Y., Cheng, C.-Y. C., Dalli, J., & Serhan, C. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102362 · Cited by 188
“quently converted to 13S,14S-epoxy-maresin [6].”
BackgroundSelf-citationMaresin 1 mitigates LPS‐induced acute lung injury in mice
Gong, J., Wu, Z., Qi, H., Chen, L., Li, H., Li, B., Yao, C., Wang, Y., Wu, J., Yuan, S., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12714 · Cited by 186
“Dalli et al. (2013) speculated that the novel 13S,14S-epoxy-maresin is converted by human macrophages to MaR1, which inhibits leukotriene A4 hydrolase and shifts macrophage phenotype.”
BackgroundSun, Q., Wu, Y., Zhao, F., & Wang, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9634803 · Cited by 185
Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution
Das, U. N. (2021) · Biomolecules · doi:10.3390/biom11121873 · Cited by 180
Maresin 1 biosynthesis during platelet–neutrophil interactions is organ-protective
Abdulnour, R.-E. E., Dalli, J., Colby, J. K., Krishnamoorthy, N., Timmons, J. Y., Tan, S. H., Colas, R. A., Petasis, N. A., Serhan, C. N., & Levy, B. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407123111 · Cited by 181
“In contrast to antiinflammatory agents, this mediator does not appear to be immunosuppressive (12) and regulates hallmarks of resolution that are characteristics of SPMs (22), such as efferocytosis of apoptotic neutrophils (13) and shifting macrophage phenotype to proresolving (13), as well as tissue regeneration (12).”
BackgroundMethodSelf-citationWang, C.-W., Colas, R. A., Dalli, J., Arnardottir, H. H., Nguyen, D., Hasturk, H., Chiang, N., Van Dyke, T. E., & Serhan, C. N. (2016) · Infection and Immunity · doi:10.1128/iai.01131-15 · Cited by 179
“(A) Maresin 1 biosynthetic pathway (12, 15, 16).”
MethodInfluentialSelf-citationThe Biosynthesis of Enzymatically Oxidized Lipids
Hajeyah, A. A., Griffiths, W. J., Wang, Y., Finch, A. J., & O’Donnell, V. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591819 · Cited by 180
Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation
Colas, R. A., Dalli, J., Chiang, N., Vlasakov, I., Sanger, J. M., Riley, I. R., & Serhan, C. N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600837 · Cited by 180
“The biosynthesis of Maresin 1 (MaR1 [7R,14S-dihydroxydocosa4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid]), the first mediator identified in this family, is initiated by human macrophage 12-lipoxygenase to produce 14S-hydroperoxy-4Z,7Z,10Z,12E,16Z,19Z docosahexaenoic acid that is then converted to 13S,14S-epoxy-docosa-4Z,7Z,9E…”
BackgroundSelf-citationProresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
Norling, L. V., Headland, S. E., Dalli, J., Arnardottir, H. H., Haworth, O., Jones, H. R., Irimia, D., Serhan, C. N., & Perretti, M. (2016) · JCI Insight · doi:10.1172/jci.insight.85922 · Cited by 174
“This finding complements the array of known functions that proresolving mediators exert to repair injured tissue in the context of wound healing (42), tissue regeneration (43, 44), and restitution of gut epithelial barrier function (45).”
BackgroundSelf-citationArnardottir, H. H., Dalli, J., Colas, R. A., Shinohara, M., & Serhan, C. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401313 · Cited by 170
“SPMs are now appreciated as regulators, as well as markers, of M1 and M2 macrophage phenotypes (2), where they promote class-switch toward an anti-inflammatory and proresolving M2like phenotype (12, 15, 27, 28).”
BackgroundSelf-citationFrancos-Quijorna, I., Santos-Nogueira, E., Gronert, K., Sullivan, A. B., Kopp, M. A., Brommer, B., David, S., Schwab, J. M., & López-Vales, R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1395-17.2017 · Cited by 163
“MaR1 was reported previously to shift the macrophage phenotype toward M2 in cell culture (Dalli et al., 2013).”
BackgroundHan, Y.-H., Shin, K.-O., Kim, J.-Y., Khadka, D. B., Kim, H.-J., Lee, Y.-M., Cho, W.-J., Cha, J.-Y., Lee, B.-J., & Lee, M.-O. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124219 · Cited by 154
Chang, H. Y., Lee, H., Kim, W., & Surh, Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.10.014 · Cited by 172
Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
Dalli, J., & Serhan, C. N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01400 · Cited by 146
Self-citationN-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 147
Dalli, J., & Serhan, C. N. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14336 · Cited by 138
Self-citationHarwood, J. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108838 · Cited by 161
“The epoxy-intermediate can then be hydrolysed by different enzymes [21] to generate maresins 1 or 2 [91,92].”
BackgroundInflammation in pathogenesis of chronic pain: Foe and friend
Fang, X.-X., Zhai, M.-N., Zhu, M., He, C., Wang, H., Wang, J., & Zhang, Z. (2023) · Molecular Pain · doi:10.1177/17448069231178176 · Cited by 162
Self-citationPark, J., Langmead, C. J., & Riddy, D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00075 · Cited by 143
NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase
Kolawole, O. R., & Kashfi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031432 · Cited by 148
“These findings show the role of maresins in regulating proinflammatory lipid mediators in addition to their anti-inflammatory actions, either directly or by way of precursors along the biosynthetic pathways [325].”
BackgroundMacrophage Proresolving Mediators—the When and Where
Dalli, J., & Serhan, C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0001-2014 · Cited by 121
“Incubation of 13S,14S-epoxy-DHA with M1 macrophages led to a change in macrophage phenotype toward an M2 profile (73).”
BackgroundSelf-citationUnderstanding dental pulp inflammation: from signaling to structure
Pohl, S., Akamp, T., Smeda, M., Uderhardt, S., Besold, D., Krastl, G., Galler, K. M., Buchalla, W., & Widbiller, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474466 · Cited by 156
Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders
Yang, T., Xu, G., Newton, P. T., Chagin, A. S., Mkrtchian, S., Carlström, M., Zhang, X., Harris, R. A., Cooter, M. L., Berger, M., et al. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.10.062 · Cited by 122
Human health benefits of very-long-chain polyunsaturated fatty acids from microalgae
Lupette, J., & Benning, C. (2020) · Biochimie · doi:10.1016/j.biochi.2020.04.022 · Cited by 115
Dalli, J., Chiang, N., & Serhan, C. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415006111 · Cited by 115
Self-citationOxidation of Polyunsaturated Fatty Acids and its Impact on Food Quality and Human Health
Tao, L. (2015) · Advanced in Food Technology and Nutritional Sciences - Open Journal · doi:10.17140/aftnsoj-1-123 · Cited by 149
Bioactive metabolites of docosahexaenoic acid
Kuda, O. (2017) · Biochimie · doi:10.1016/j.biochi.2017.01.002 · Cited by 125
“Total organic (stereoselective) synthesis, preferably coupled to biosynthesis, was achieved for Maresin 1[91], Maresin 2 [92], eMaresin [38],MCTRs [41, 42], 14,20- and 14,21-diHDHA [44, 93], PD1, AT-PD1, PDX [94-96], 22-OH-PD1 [46], PCTRs [97, 98], RvD1 and AT-RvD1 [99], RvD2 [100, 101], RvD3 and AT-RvD3 [102], RvD4 […”
Towards targeting resolution pathways of airway inflammation in asthma
Barnig, C., Frossard, N., & Levy, B. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.004 · Cited by 121
Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation
Sugimoto, S., Mena, H. A., Sansbury, B. E., Kobayashi, S., Tsuji, T., Wang, C., Yin, X., Huang, T. L., Kusuyama, J., Kodani, S. D., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00590-0 · Cited by 128
Martínez-Fernández, L., González-Muniesa, P., Laiglesia, L. M., Sáinz, N., Prieto-Hontoria, P. L., Escoté, X., Odriozola, L., Corrales, F. J., Arbones-Mainar, J. M., Martínez, J. A., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600859r · Cited by 105
“13S,14S-epoxy-maresin, an intermediate in the biosynthesis of MaR1, has been reported to switch human macrophages to the anti-inflammatory M2 phenotype, leading to a higher production of MaR1 (35), although the direct effects of MaR1 on macrophage phenotype had not been reported.”
BackgroundAkagi, D., Chen, M., Toy, R., Chatterjee, A., & Conte, M. S. (2015) · The FASEB Journal · doi:10.1096/fj.14-265363 · Cited by 104
“Recent reports showed that a precursor of MaR1 shifted phenotype of macrophages from M1 to M2 in vitro (45).”
BackgroundKulkarni, O. P., Lichtnekert, J., Anders, H., & Mulay, S. R. (2016) · Mediators of Inflammation · doi:10.1155/2016/2856213 · Cited by 128
“They potently inhibit the release of proinflammatory cytokines from the group 2 innate lymphoid cells (ILCs) [20] and increase IL-10 production by macrophages as well as induce M1 to M2 macrophage phenotype switch [21].”
BackgroundMaresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages
Dalli, J., Vlasakov, I., Riley, I. R., Rodríguez, A. R., Spur, B. W., Petasis, N. A., Chiang, N., & Serhan, C. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607003113 · Cited by 105
“The lipoxygenase responsible for 14-lipoxygenation and epoxidation reactions in human macrophages is human 12-LOX (16, 21).”
BackgroundInfluentialSelf-citationResolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages
Croasdell, A., Thatcher, T. H., Kottmann, R. M., Colas, R. A., Dalli, J., Serhan, C. N., Sime, P. J., & Phipps, R. P. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00125.2015 · Cited by 99
Self-citationSerhan, C. N., Libreros, S., & Nshimiyimana, R. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101597 · Cited by 108
Self-citationTang, S. J., Wan, M., Huang, W. G., Stanton, R. C., & Xu, Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/2380319 · Cited by 96
“Interestingly, the 13S, 14S-epoxide intermediates only inhibit the conversion of 12-LOX to arachidonic (eicosatetraenoic) acid and do not play a role in DHA conversion, suggesting that 13S,14Sepoxide intermediates can exert a positive feedback on the maresin synthesis pathway and enhance resolution of the inflammation…”
BackgroundSpecialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases
Krishnamoorthy, N., Abdulnour, R.-E. E., Walker, K. H., Engstrom, B. D., & Levy, B. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00026.2017 · Cited by 89
EPA- and DHA-derived resolvins' actions in inflammatory bowel disease
Schwanke, R. C., Marcon, R., Bento, A. F., & Calixto, J. Β. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.050 · Cited by 89
“Recent studies have revealed that RvD (1–4), AT-RvD (1–4), 17R HDHA, 17S HDHA, 17S-protectin D1, 17R-protectin D1, and maresin even at low concentrations (nanomolar or picomolar) exert potent anti-inflammatory and immunoregulatory actions in animal models (Bannenberg et al., 2005; Bento et al., 2011; Dalli et al., 201…”
BackgroundXian, W., Wu, Y., Xiong, W., Li, L., Li, T., Pan, S., Song, L., Hu, L., Pei, L., Yao, S., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.090 · Cited by 88
Dual Roles of Group IID Phospholipase A2 in Inflammation and Cancer
Miki, Y., Kidoguchi, Y., Sato, M., Taketomi, Y., Taya, C., Muramatsu, K., Gelb, M. H., Yamamoto, K., & Murakami, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734624 · Cited by 85
“Given that some 3 PUFA metabolites facilitate M2 polarization of macrophages (36, 37), our observations suggesting that tumor-associated M2-like macrophages, which promote cancer progression by releasing a panel of factors that prevent the recruitment or functions of cytotoxic T and NK cells (34), are reduced in Pla2g…”
BackgroundHepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79
“At least some of these lipid metabolites are produced by macrophages (101) and also signal to macrophages to reduce inflammatory and fibrogenic gene expression (102).”
BackgroundRodríguez, M. J., Sabaj, M., Tolosa, G., Vielma, F. H., Zúñiga, M. J., González, D. R., & Zúñiga‐Hernández, J. (2021) · Cells · doi:10.3390/cells10123406 · Cited by 92
“The anti-inflammatory and pro-resolutive activity of MaR1 could be mediated by their capacity to shift macrophage to an M2 antiinflammatory phenotype [8], where MaR1 incubation with macrophages resolution, by increasing phagocytosis and efferocytosis [55], and an epoxy-DHA (eMaR), stimulates the conversion of the M1 m…”
BackgroundA systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch
Ramsden, C. E., Domenichiello, A. F., Yuan, Z., Sapio, M. R., Keyes, G. S., Mishra, S. K., Gross, J. R., Majchrzak‐Hong, S. F., Zamora, D., Horowitz, M. S., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal5241 · Cited by 79
Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
Markworth, J. F., Brown, L. A., Lim, E. Y., Floyd, C., Larouche, J. A., Castor‐Macias, J. A., Sugg, K. B., Sarver, D. C., Macpherson, P. C. D., Davis, C. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137713 · Cited by 85
Maresin-1 and Inflammatory Disease
Saito‐Sasaki, N., Sawada, Y., & Nakamura, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031367 · Cited by 86
Murase, R., Sato, H., Yamamoto, K., Ushida, A., Nishito, Y., Ikeda, K., Kobayashi, T., Yamamoto, T., Taketomi, Y., & Murakami, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.715672 · Cited by 81
“3 PUFA metabolites promote M2 macrophage polarization (58, 59), prevent T cell activation or differentiation (60, 61), and alter antibody production by B cells (62), a view that is relevant to the phenotypes observed in PLA2G10 mice.”
BackgroundYin, P., Wang, X., Wang, S., Wei, Y., Feng, J., & Zhu, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00466 · Cited by 73
Self-citationLukic, A., Larssen, P., Fauland, A., Samuelsson, B. O., Wheelock, C. E., Gabrielsson, S., & Rådmark, O. (2017) · The FASEB Journal · doi:10.1096/fj.201700319r · Cited by 79
“M1 Mfs were incubated with 13S,14S-epoxy-maresin, which down-regulatedCD54 andCD80 and up-regulated CD163 and CD206, indicating a change toward the M2 phenotype (50).”
MethodLipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
Brennan, E. P., Mohan, M., McClelland, A., Tikellis, C., Ziemann, M., Kaspi, A., Gray, S. P., Pickering, R. J., Tan, S. M., Shah, S. T. A., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017101112 · Cited by 76
Cash, J. L., Bass, M. D., Campbell, J., Barnes, M., Kubes, P., & Martin, P. (2014) · Current Biology · doi:10.1016/j.cub.2014.05.006 · Cited by 71
Cezar, T. L. C., Martinez, R. M., da Rocha, C., Melo, C. P. B., do Vale, D. L., Borghi, S. M., Fattori, V., Vignoli, J. A., Camilios‐Neto, D., Baracat, M. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39584-6 · Cited by 78
Ungaro, F., Rubbino, F., Danese, S., & D’Alessio, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01331 · Cited by 79
Maresin 1 Promotes Wound Healing and Socket Bone Regeneration for Alveolar Ridge Preservation
Wang, C., Yu, S. H., Fretwurst, T., Larsson, L., Sugai, J. V., Oh, J., Lehner, K. A., Jin, Q., & Giannobile, W. V. (2020) · Journal of Dental Research · doi:10.1177/0022034520917903 · Cited by 69
“Additionally, the MaR1 pathway stimulates macrophage phenotype switching from proinflammatory M1- to M2-like macrophages in vitro and in vivo (Dalli et al. 2013; Marcon et al. 2013; Viola et al. 2016), and M2 phenotypes are responsible for healing and tissue regeneration (Martinez et al.”
BackgroundRius, B., Duran‐Güell, M., Flores‐Costa, R., López‐Vicario, C., Lopategi, A., Alcaraz‐Quiles, J., Casulleras, M., José Lozano, J., Titos, E., & Clària, J. (2017) · The FASEB Journal · doi:10.1096/fj.201700394r · Cited by 68
“In humans, MaR1 is generated from DHA through the activity of the 12-LOX enzyme, which mouse homolog is 12/15-LOX (21-23).”
BackgroundInfluentialSezin, T., Krajewski, M. P., Wutkowski, A., Mousavi, S., Chakievska, L., Bieber, K., Ludwig, R. J., Dahlke, M., Rades, D., Schulze, F. S., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.021 · Cited by 69
Vik, A., Dalli, J., & Hansen, T. V. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.079 · Cited by 72
Self-citationLavy, M., Gauttier, V., Poirier, N., Barillé‐Nion, S., & Blanquart, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702785 · Cited by 79
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Vartak, T., Godson, C., & Brennan, E. P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113965 · Cited by 72
Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3
Dalli, J., Sanger, J. M., Rodríguez, A. R., Chiang, N., Spur, B. W., & Serhan, C. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149319 · Cited by 72
“We recently determined the complete stereochemistry of a key intermediate in maresin biosynthetic pathway 13S,14S-epoxy maresin [12], the proposed intermediate and immediate precursor in MCTR production (Fig 1A and [2]).”
Self-citationUse of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
Land, W. G. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00460-z · Cited by 74
Serhan, C. N., de la Rosa, X., & Jouvene, C. C. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12871 · Cited by 70
Self-citationRegulation of Apoptotic Cell Clearance During Resolution of Inflammation
Arienti, S., Barth, N. D., Dorward, D. A., Rossi, A. G., & Dransfield, I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00891 · Cited by 67
Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma
Kytikovа, O. Y., Novgorodtseva, T. P., Denisenko, Y., Antonyuk, M. V., & Gvozdenko, T. A. (2019) · Medicina · doi:10.3390/medicina55060284 · Cited by 66
“There are three subtypes of activated macrophages: classically activated (M1), alternatively activated (M2) macrophages and resolution-phase macrophages [28].”
BackgroundAlterations of Lipid Profile in COVID-19: A Narrative Review
Rezaei, A., Neshat, S., & Heshmat‐Ghahdarijani, K. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100907 · Cited by 64
“They also stimulate wound healing and induce tissue regeneration.(65) The biosynthesis of SPMs highly depends on PUFAs, most importantly on DHA and ETA.”
PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function
Pistorius, K., Souza, P. R., Matteis, R. D., Austin‐Williams, S., Primdahl, K. G., Vik, A., Mazzacuva, F., Colas, R. A., Marques, R. M., Hansen, T. V., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.04.017 · Cited by 62
“Of note, PD1n-3 DPA and PD2n-3 DPA carry potent leukocyte directed actions, reducing neutrophil recruitment as well as the production of inflammatory cytokines, including monocyte chemoattractant protein-1, during sterile inflammation (Dalli et al., 2013a).”
BackgroundMethodResultInfluentialSelf-citationYum, H.-W., Na, H., & Surh, Y. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.004 · Cited by 64
Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
Torrinhas, R. S., Calder, P. C., Lemos, G. O., & Waitzberg, D. L. (2021) · Nutrition · doi:10.1016/j.nut.2020.110900 · Cited by 57
“With their action of contra-regulation of proinflammatory mediators, SPMs have been shown to decrease inflammation magnitude and duration, and stimulate reepithelization, wound healing, and tissue regeneration in experimental models [25].”
BackgroundThe Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration
Hwang, S.-M., Chung, G., Kim, Y. H., & Park, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235849 · Cited by 64
“MaRs are believed to act as potent protective mediators of macrophage function [39,40] and promote the resolution of acute inflammation and tissue regeneration [23,41,42].”
BackgroundNeutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease
He, W., Yan, L., Hu, D., Hao, J., Liou, Y., & Luo, G. (2025) · MedComm · doi:10.1002/mco2.70063 · Cited by 68
Tang, S. J., Gao, C., Long, Y., Huang, W. G., Chen, J., Fan, F., Jiang, C., & Xu, Y. (2017) · Mediators of Inflammation · doi:10.1155/2017/2438247 · Cited by 58
“Researches in inflammation-related disease have proved that maresin 1 plays a protective role in the body by limiting neutrophil infiltration, enhancing macrophage phagocytosis, decreasing the production of proinflammatory cytokines, inhibiting NF-PB activation, and so on [19, 20].”
BackgroundLu, J., Feng, X., Zhang, H., Wei, Y., Yang, Y., Tian, Y., & Bai, L. (2020) · Connective Tissue Research · doi:10.1080/03008207.2020.1780218 · Cited by 52
Ramsden, C. E., Ringel, A., Majchrzak‐Hong, S. F., Yang, J., Blanchard, H. C., Zamora, D., Loewke, J., Rapoport, S. I., Hibbeln, J. R., Davis, J. M., et al. (2016) · Molecular Pain · doi:10.1177/1744806916636386 · Cited by 61
The role of lipid-based signalling in wound healing and senescence
Pils, V., Terlecki‐Ζaniewicz, L., Schosserer, M., Grillari, J., & Lämmermann, I. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111527 · Cited by 61
“13S,14S-epoxy-DHA, a precursor of MaR1, stimulates M1 to M2 macrophage phenotype-switch and inhibits leukotriene A4 hydrolase (LTA4H) that synthesizes LTB4 (Dalli et al., 2013).”
BackgroundVidela, L. A., Valenzuela, R., del Campo, A., & Zúñiga‐Hernández, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115528 · Cited by 58
“MaRs not only is produced by human macrophages, but it also shifted macrophage phenotype from a CD54 + CD80 + M1 to a CD163 + CD206 + M2 phenotype [101].”
Background
Metadata
- Authors
- Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Southern California (US)
- Karolinska Institutet (SE)
- Corresponding author
- Petasis, Nicos A.
- Serhan, Charles N.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-03-15
- Volume
- 27
- Issue
- 7
- Pages
- 2573-2583
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3688739
- OpenAlex
- W2100994932
- Cited by
- 283
- References
- 32
- Citations by year
- 2026: 20 · 2025: 14 · 2024: 13 · 2023: 25 · 2022: 23 · 2021: 23 · 2020: 30 · 2019: 19 · 2018: 28 · 2017: 26 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 4
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P01GM095467)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- maresin 1, epoxyeicosatrienoic acids, docosahexaenoic acid, 12-lipoxygenase, leukotriene A4 hydrolase, macrophage phenotype, leukotriene B4, specialized pro-resolving mediators, eicosanoid biosynthesis
- MeSH terms
- Arachidonate 12-Lipoxygenase, Cells, Cultured, Docosahexaenoic Acids, Epoxide Hydrolases, Humans, Leukotriene B4, Macrophages, Models, Chemical, Magnetic Resonance Spectroscopy, Molecular Structure, Arachidonic Acid, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.